Bayer

After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT
After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT
Endpoints
Bayer
R&D
layoffs
Cambridge MA
MIT
Flag link:
The top 15 pharma companies by 2018 revenue
The top 15 pharma companies by 2018 revenue
Fierce Pharma
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Flag link:
Bayer, after cyberattack, finds 'no evidence' hackers obtained data
Bayer, after cyberattack, finds 'no evidence' hackers obtained data
Fierce Pharma
Bayer
cyberattack
hacking
cybersecurity
Flag link:
Bayer posts early clinical data on follow-up to Loxo’s Vitrakvi
Bayer posts early clinical data on follow-up to Loxo’s Vitrakvi
Fierce Biotech
Bayer
Loxo Oncology
solid tumors
AACR
Flag link:
Bayer loses bid to toss some claims in Essure class action suit
Bayer loses bid to toss some claims in Essure class action suit
Mass Device
Bayer
Essure
devices
contraceptives
Flag link:
Bayer and J&J settle Xarelto lawsuits in US
Bayer and J&J settle Xarelto lawsuits in US
Pharmaforum
Bayer
JNJ
Xarelto
Flag link:
Bayer animal health sale could rake in $8B and bids from private equity: report
Bayer animal health sale could rake in $8B and bids from private equity: report
Fierce Pharma
Bayer
animal health
M&A
Flag link:
ACC 2019 preview – Bayer hopes for heart failure panache
ACC 2019 preview – Bayer hopes for heart failure panache
EP Vantage
Bayer
heart failure
Amarin
Esperion
ACC
Vascepa
bempedoic acid
Flag link:
Bayer files prostate cancer drug darolutamide with EU regulators
Bayer files prostate cancer drug darolutamide with EU regulators
Pharmaforum
Bayer
Europe
darolutamide
prostate cancer
Flag link:
Bayer files prostate cancer drug darolutamide in Japan
Bayer files prostate cancer drug darolutamide in Japan
Pharmaforum
Bayer
prostate cancer
darolutamide
Japan
JNJ
Pfizer
Astellas
Flag link:
Sanofi, Bayer and Roche execs underscore the value of digital therapeutics
Sanofi, Bayer and Roche execs underscore the value of digital therapeutics
MedCity
digital therapeutics
Sanofi
Bayer
Roche
Flag link:
Evotec Receives Milestone Payment for Initiating Ph II Trials of Persistent Cough Drug
Evotec Receives Milestone Payment for Initiating Ph II Trials of Persistent Cough Drug
CP Wire
Evotec
Bayer
chronic cough
Flag link:
Evotec Receives Milestone Payment for Initiating Ph II Trials of Persistent Cough Drug
Evotec
Bayer
Flag link:
With Bayer predicting slowdowns for Xarelto and Eylea, what will fill the gap?
With Bayer predicting slowdowns for Xarelto and Eylea, what will fill the gap?
Fierce Pharma
Bayer
Xarelto
Eylea
Flag link:
Bayer to cut 200 jobs at U.S. logistics center as it alters course for pharma
Bayer to cut 200 jobs at U.S. logistics center as it alters course for pharma
Fierce Pharma
Bayer
restructuring
animal health
layoffs
Flag link:
Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo
Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo
Yahoo/Reuters
Bayer
Vitrakvi
cancer
Eli Lilly
Loxo Oncology
Flag link:
Bayer stresses drug's tolerability in bid for prostate cancer market
Bayer stresses drug's tolerability in bid for prostate cancer market
Yahoo/Reuters
Bayer
prostate cancer
darolutamide
Pfizer
JNJ
Flag link:
Artificial Intelligence Gaining Ground in Drug Development
Artificial Intelligence Gaining Ground in Drug Development
BioSpace
CASP
machine learning
artificial intelligence
drug development
Merck
Takeda
Atomwise
Bayer
GSK
Google DeepMind
Recursion Pharmaceuticals
Flag link:
Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement
Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement
BioSpace
Takeda
clinical trials
Adynovate
Baxalta
Bayer
patents
Flag link:
Bayer to increase patient access to specialty drugs with ZappRx digital platform
Bayer to increase patient access to specialty drugs with ZappRx digital platform
BioCentury
Bayer
ZappRx
patients
pulmonary hypertension
Relapsing Remitting Multiple Sclerosis
Adempas riociguat
IFNβ-1b Betaferon
Flag link:

Pages